Cargando…

Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities

BACKGROUND: For adolescents and young adults (AYAs, aged 15-39 years) with cancer, metastatic disease at diagnosis is the strongest predictor of mortality, but its associations with age and sociodemographic factors are largely unexplored. METHODS: Using Surveillance, Epidemiology, and End Results Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheth Bhutada, Jessica, Hwang, Amie, Liu, Lihua, Deapen, Dennis, Freyer, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266435/
https://www.ncbi.nlm.nih.gov/pubmed/34250441
http://dx.doi.org/10.1093/jncics/pkab039
_version_ 1783719944879341568
author Sheth Bhutada, Jessica
Hwang, Amie
Liu, Lihua
Deapen, Dennis
Freyer, David R
author_facet Sheth Bhutada, Jessica
Hwang, Amie
Liu, Lihua
Deapen, Dennis
Freyer, David R
author_sort Sheth Bhutada, Jessica
collection PubMed
description BACKGROUND: For adolescents and young adults (AYAs, aged 15-39 years) with cancer, metastatic disease at diagnosis is the strongest predictor of mortality, but its associations with age and sociodemographic factors are largely unexplored. METHODS: Using Surveillance, Epidemiology, and End Results Program data from 2000 to 2016, we collected incident cases of poor-prognosis metastatic cancer (5-year survival < 50%) and compared the proportion, incidence, time trends, and incidence rate ratios for race and ethnicity, sex, and socioeconomic status among AYAs, middle-aged adults (aged 40-64 years) and older adults (aged 65-79 years). RESULTS: From 2000 to 2016, a total of 17 210 incident cases of poor-prognosis metastatic cancer were diagnosed in AYAs, 121 274 in middle-aged adults, and 364 228 in older adults. Compared with older patients, the proportion of AYAs having metastatic disease was equivalent or substantially lower in nearly every site except stomach and breast cancers, which were statistically significantly higher for AYAs compared with middle-aged and older adults (stomach: 57.3% vs 46.4% and 39.5%; breast: 6.6% vs 4.4% and 5.6%, respectively; 2-sided P < .001 for all comparisons). Incidence rates rose significantly faster among AYAs for breast, stomach, and kidney cancers and among AYAs and middle-aged adults for colorectal cancer. Markedly higher incidence rate ratios were noted for AYA racial and ethnic minorities with breast, stomach, and especially kidney cancer, where only non-Hispanic Black AYAs were at considerably higher risk. For most sites, incidence rate ratios were higher among male patients and individuals of low socioeconomic status across age groups. CONCLUSIONS: For most cancers, AYAs are not more likely to present with metastases than middle-aged and older adults. Further investigation is warranted for the disproportionate rise in incidence of metastatic breast, stomach, and kidney cancer among AYAs and their excess burden among AYA racial and ethnic minorities. The rising incidence of colorectal cancer among AYAs and middle-aged adults remains an additional concern.
format Online
Article
Text
id pubmed-8266435
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82664352021-07-09 Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities Sheth Bhutada, Jessica Hwang, Amie Liu, Lihua Deapen, Dennis Freyer, David R JNCI Cancer Spectr Article BACKGROUND: For adolescents and young adults (AYAs, aged 15-39 years) with cancer, metastatic disease at diagnosis is the strongest predictor of mortality, but its associations with age and sociodemographic factors are largely unexplored. METHODS: Using Surveillance, Epidemiology, and End Results Program data from 2000 to 2016, we collected incident cases of poor-prognosis metastatic cancer (5-year survival < 50%) and compared the proportion, incidence, time trends, and incidence rate ratios for race and ethnicity, sex, and socioeconomic status among AYAs, middle-aged adults (aged 40-64 years) and older adults (aged 65-79 years). RESULTS: From 2000 to 2016, a total of 17 210 incident cases of poor-prognosis metastatic cancer were diagnosed in AYAs, 121 274 in middle-aged adults, and 364 228 in older adults. Compared with older patients, the proportion of AYAs having metastatic disease was equivalent or substantially lower in nearly every site except stomach and breast cancers, which were statistically significantly higher for AYAs compared with middle-aged and older adults (stomach: 57.3% vs 46.4% and 39.5%; breast: 6.6% vs 4.4% and 5.6%, respectively; 2-sided P < .001 for all comparisons). Incidence rates rose significantly faster among AYAs for breast, stomach, and kidney cancers and among AYAs and middle-aged adults for colorectal cancer. Markedly higher incidence rate ratios were noted for AYA racial and ethnic minorities with breast, stomach, and especially kidney cancer, where only non-Hispanic Black AYAs were at considerably higher risk. For most sites, incidence rate ratios were higher among male patients and individuals of low socioeconomic status across age groups. CONCLUSIONS: For most cancers, AYAs are not more likely to present with metastases than middle-aged and older adults. Further investigation is warranted for the disproportionate rise in incidence of metastatic breast, stomach, and kidney cancer among AYAs and their excess burden among AYA racial and ethnic minorities. The rising incidence of colorectal cancer among AYAs and middle-aged adults remains an additional concern. Oxford University Press 2021-04-27 /pmc/articles/PMC8266435/ /pubmed/34250441 http://dx.doi.org/10.1093/jncics/pkab039 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Sheth Bhutada, Jessica
Hwang, Amie
Liu, Lihua
Deapen, Dennis
Freyer, David R
Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities
title Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities
title_full Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities
title_fullStr Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities
title_full_unstemmed Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities
title_short Poor-Prognosis Metastatic Cancers in Adolescents and Young Adults: Incidence Patterns, Trends, and Disparities
title_sort poor-prognosis metastatic cancers in adolescents and young adults: incidence patterns, trends, and disparities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266435/
https://www.ncbi.nlm.nih.gov/pubmed/34250441
http://dx.doi.org/10.1093/jncics/pkab039
work_keys_str_mv AT shethbhutadajessica poorprognosismetastaticcancersinadolescentsandyoungadultsincidencepatternstrendsanddisparities
AT hwangamie poorprognosismetastaticcancersinadolescentsandyoungadultsincidencepatternstrendsanddisparities
AT liulihua poorprognosismetastaticcancersinadolescentsandyoungadultsincidencepatternstrendsanddisparities
AT deapendennis poorprognosismetastaticcancersinadolescentsandyoungadultsincidencepatternstrendsanddisparities
AT freyerdavidr poorprognosismetastaticcancersinadolescentsandyoungadultsincidencepatternstrendsanddisparities